Higher-Dose Dexamethasone Improves Breathing and Shortens NICU Stay in Preterm Babies
NCT07765329 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-08-14
Summary
The goal of this observational study was to compare two doses of dexamethasone given to pregnant women at risk of preterm birth. Dexamethasone is a medicine used before birth to help a baby's lungs mature.
This study looked at preterm babies born between 26 and 36 weeks of pregnancy. Researchers compared babies whose mothers received dexamethasone 12 mg every 12 hours for 48 hours with babies whose mothers received dexamethasone 6 mg every 12 hours for 48 hours.
The main questions this study aimed to answer were:
* Did the higher dose of dexamethasone help preterm babies need breathing support for a shorter time?
* Did the higher dose help shorten the babies' stay in the Neonatal Intensive Care Unit (NICU)?
* Was the higher dose as safe as the lower dose for babies and mothers?
Researchers reviewed medical records from Stella Maris Women's and Children's Hospital from January 2018 to January 2023. They looked at neonatal outcomes, including breathing support, respiratory distress syndrome, length of NICU stay, low blood sugar in babies, infection in mothers, and developmental problems at 24 months.
Conditions
- Premature Birth
- Neonatal Hypoglycemia
- Maternal Infection During Pregnancy
- Neurodevelopmental Disorder of Foetus
- Respiratory Distress Syndrome (RDS)
- Necrotizing Enterocolitis (NEC)
- Intraventricular Hemorrhage Neonatal
- Neonatal Sepsis
- Intraventricular Hemorrhage (IVH)
- Neonatal Respiratory Distress Syndrome
Interventions
- DRUG
-
Dexamethasone 12 mg Every 12 Hours
Pregnant women at risk of preterm birth received antenatal dexamethasone 12 mg every 12 hours for 48 hours for fetal lung maturation. Neonatal outcomes were compared with those of infants whose mothers received the lower-dose dexamethasone regimen.
- DRUG
-
Dexamethasone 6 mg Every 12 Hours
Pregnant women at risk of preterm birth received antenatal dexamethasone 6 mg every 12 hours for 48 hours for fetal lung maturation. This regimen was compared with dexamethasone 12 mg every 12 hours.
Sponsors & Collaborators
-
Universitas Sumatera Utara
collaborator OTHER -
Stella Maris Women and Children Hospital
lead OTHER
Eligibility
- Min Age
- 26 Weeks
- Max Age
- 36 Weeks
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-01-01
- Primary Completion
- 2023-01-31
- Completion
- 2026-06-01
Countries
- Indonesia
Study Locations
More Related Trials
-
Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE)
NCT00005777 ·Status: TERMINATED ·Phase: PHASE3
-
Antenatal Corticoid Therapy for Late Preterm Babies
NCT00675246 ·Status: COMPLETED ·Phase: NA
-
Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDS
NCT06188195 ·Status: RECRUITING ·Phase: NA
-
Dose Reduction of Antenatal Betamethasone Given to Prevent the Neonatal Complications Associated With Very Preterm Birth
NCT02897076 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Antenatal Corticosteroids on Neonatal Morbidity.
NCT03446937 ·Status: COMPLETED ·Phase: NA
-
Study of Antenatal Thyrotropin-Releasing Hormone in Women in Premature Labor to Prevent Lung Disease in Preterm Infants
NCT00004840 ·Status: COMPLETED ·Phase: NA
-
Maternal and Fetal/Neonatal Pharmacokinetics and - Dynamics of Corticosteroids During Pregnancy
NCT06264973 ·Status: RECRUITING
-
Efficacy of Dexmedetomidine Versus Midazolam Sedation on Extubation Time in Mechanically Ventilated Preterm Infants
NCT06878703 ·Status: RECRUITING ·Phase: PHASE3
-
Prenatal Dex Study
NCT02795871 ·Status: COMPLETED ·Phase: NA
-
The Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age
NCT02636868 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Antenatal Steroid on Pulmonary Artery Blood Flow
NCT02978976 ·Status: UNKNOWN ·Phase: PHASE4
-
Hematological Profiles of Preterm Infants and the Impact of Antenatal Steroids
NCT07358845 ·Status: COMPLETED
-
Can Betamethasone Given After Birth Help Extremely Premature Babies Come Off Breathing Support Safely and Effectively?
NCT07447739 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
High-Dose Intravenous Lipid for Very Preterm or Very Low Birth Weight Infants Effects on Growth
NCT06909929 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD
NCT03857841 ·Status: TERMINATED ·Phase: PHASE1
-
Antenatal Late Preterm Steroids (ALPS): A Randomized Placebo-Controlled Trial
NCT01222247 ·Status: COMPLETED ·Phase: PHASE3
-
Late Preterm Corticosteroids and Neonatal Hypoglycemia
NCT04869709 ·Status: UNKNOWN ·Phase: PHASE4
-
BETAmethasone Dose Reduction: Non-Inferiority on the Neurocognitive Outcomes of Children Born Before 32 Weeks of Gestation
NCT04021485 ·Status: RECRUITING ·Phase: NA
-
A Safety and Efficacy Study of Lucinactant for Inhalation in Preterm Neonates 26 to 32 Weeks Gestational Age
NCT04264156 ·Status: TERMINATED ·Phase: PHASE2
-
Ultrasonographic Evaluation of Fetal Adrenal Gland in Cases of Threatened Preterm Labor
NCT03251794 ·Status: COMPLETED
-
Doxapram Therapy in Preterm Infants (DOXA Trial)
NCT04430790 ·Status: RECRUITING ·Phase: PHASE3
-
Effect of Steroid Administration on Maternal Blood Levels of hLPCAT1 mRNA
NCT03562182 ·Status: UNKNOWN
-
Effects of L-Carnitine Supplementation on Respiratory Distress Syndrome
NCT03630367 ·Status: WITHDRAWN ·Phase: PHASE4
-
Antenatal Corticosteroid Therapy: Which Impact on Birth Parameters?
NCT05640596 ·Status: COMPLETED
-
Work of Breathing in Premature Infants at Discharge
NCT03682575 ·Status: COMPLETED